{"schema_version":"secwatch.filing_event.v1","accession":"0001140361-24-001339","form_type":"8-K","ticker":"SSKN","cik":"0001051514","company_name":"STRATA Skin Sciences, Inc.","filed_at":"2024-01-08T23:59:59+00:00","discovered_at":"2026-05-14T18:03:23.236297+00:00","generated_at":"2026-06-07T01:56:04.102063+00:00","sec_items":["7.01","9.01"],"event_type":"other","sentiment":"positive","materiality_score":0.25,"calibrated_materiality_score":0.25,"confidence":"medium","headline":"STRATA Skin Sciences presents TheraClear®X acne study at Maui Derm 2024","bullets":["Poster reports one treatment session using TheraClear®X with needle insert for cystic and papular acne.","Majority of lesions achieved ≥50% clearing by 1-2 weeks; average reduction score 3.5 (50-75% reduction).","Most frequent adverse event was mild hyperpigmentation; erythema, edema, flaking seen in ≤10% of lesions.","Conference takes place Jan 22-26, 2024 at Grand Wailea in Maui, Hawaii."],"urls":{"canonical":"https://secwatch.observer/filing/0001140361-24-001339","json":"https://secwatch.observer/filing/0001140361-24-001339.json","markdown":"https://secwatch.observer/filing/0001140361-24-001339.md","text":"https://secwatch.observer/filing/0001140361-24-001339.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1051514/000114036124001339/0001140361-24-001339-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1051514/000114036124001339/ef20018284_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-07T01:56:04.102063+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}